| RS104893964 |
GJA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculodentodigital dysplasia, autosomal recessive |
| RS104893965 |
GJA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect and common atrioventricular junction, Hypoplastic left heart syndrome 1 |
| RS104893966 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS104893967 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Likely pathogenic |
Cone dystrophy 3, Retinitis pigmentosa |
| RS104893968 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 3, Macular dystrophy |
| RS104893969 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, MOCS1-related disorder |
| RS104893970 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Inborn genetic diseases |
| RS104893971 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 1, Sialidosis type 1 |
| RS104893972 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS104893973 |
IFNGR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 27A, Mycobacterium tuberculosis |
| RS104893974 |
IFNGR1
|
Health Risk |
Pathogenic |
Immunodeficiency 27A, Immunodeficiency 27A |
| RS104893975 |
LHFPL5
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 67, Autosomal recessive nonsyndromic hearing loss 67 |
| RS104893977 |
NEU1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialidosis type 2, Autosomal recessive NEU1-related disorders |
| RS104893978 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS104893979 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 1, Sialidosis type 1 |
| RS104893980 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS104893981 |
NEU1
|
Health Risk |
Likely pathogenic |
Sialidosis type 2, Sialidosis |
| RS104893983 |
NEU1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialidosis type 1, Sialidosis type 1 |
| RS104893984 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis |
| RS104893985 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS104893986 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, NEU1-related disorder |
| RS104893988 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893989 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893990 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893991 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome |
| RS104893992 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893993 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysplasia 1 |
| RS104893994 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893995 |
RUNX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS104893996 |
STX11
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis 4 |
| RS104893998 |
TREM2
|
Health Risk |
Likely pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS104894001 |
TREM2
|
Health Risk |
Likely pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS104894002 |
TREM2
|
Health Risk |
Pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS104894003 |
ACTB
|
Health Risk |
Likely pathogenic |
Developmental malformations-deafness-dystonia syndrome, Baraitser-Winter syndrome 1 |
| RS104894004 |
AQP1
|
Health Risk |
Pathogenic |
Colton-null phenotype, Colton-null phenotype |
| RS104894005 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS104894006 |
GCK
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Maturity-onset diabetes of the young |
| RS104894008 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS104894009 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS104894010 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Permanent neonatal diabetes mellitus 1 |
| RS104894011 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS104894012 |
GCK
|
Health Risk |
Pathogenic |
Hyperinsulinism due to glucokinase deficiency, Hyperinsulinism due to glucokinase deficiency |
| RS104894014 |
GCK
|
Health Risk |
Pathogenic |
Hyperinsulinism due to glucokinase deficiency, Hyperinsulinism due to glucokinase deficiency |
| RS104894015 |
GCK
|
Health Risk |
Pathogenic |
Hyperinsulinism due to glucokinase deficiency, Hyperinsulinism due to glucokinase deficiency |
| RS104894016 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS104894017 |
HOXA1
|
Health Risk |
Pathogenic |
Bosley-Salih-Alorainy syndrome, Bosley-Salih-Alorainy syndrome |
| RS104894018 |
HOXA1
|
Health Risk |
Pathogenic |
Human HOXA1 syndromes, Human HOXA1 syndromes |
| RS104894019 |
HOXA13
|
Health Risk |
Pathogenic |
Hand-foot-genital syndrome, Hand-foot-genital syndrome |
| RS104894020 |
HSPB1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS104894021 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Short QT syndrome type 1, Short QT syndrome |
| RS104894023 |
LEP
|
Health Risk |
Pathogenic |
Obesity due to congenital leptin deficiency, Obesity due to congenital leptin deficiency |
| RS104894024 |
LFNG
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 3, autosomal recessive |
| RS104894025 |
NT5C3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS104894026 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS104894027 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS104894028 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS104894029 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS104894030 |
PGAM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type X, Glycogen storage disease type X |
| RS104894036 |
PSPH
|
Health Risk |
Pathogenic |
Deficiency of phosphoserine phosphatase, Deficiency of phosphoserine phosphatase |
| RS104894040 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894042 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894043 |
SHH
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 3, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS104894044 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894045 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Inborn genetic diseases |
| RS104894046 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894048 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894049 |
SHH
|
Health Risk |
Pathogenic |
Solitary median maxillary central incisor syndrome, Solitary median maxillary central incisor syndrome |
| RS104894050 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894051 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS104894052 |
SHH
|
Health Risk |
Likely pathogenic |
Solitary median maxillary central incisor syndrome, Solitary median maxillary central incisor syndrome |
| RS104894053 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Solitary median maxillary central incisor syndrome |
| RS104894054 |
TWIST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS104894055 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome with eyelid anomalies, Saethre-Chotzen syndrome |
| RS104894057 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, Saethre-Chotzen syndrome |
| RS104894058 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, Saethre-Chotzen syndrome |
| RS104894059 |
TWIST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS104894060 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 northern epilepsy variant |
| RS104894061 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS104894062 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Congenital adrenal hyperplasia |
| RS104894063 |
CHRNA2
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 4, Autosomal dominant nocturnal frontal lobe epilepsy 4 |
| RS104894064 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 8 northern epilepsy variant, Neuronal ceroid lipofuscinosis 8 |
| RS104894065 |
TWIST1
|
Health Risk |
Pathogenic |
Robinow-Sorauf syndrome, Saethre-Chotzen syndrome |
| RS104894066 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS104894067 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS104894068 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS104894069 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Congenital adrenal hyperplasia |
| RS104894070 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Congenital adrenal hyperplasia |
| RS104894071 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS104894072 |
CYP11B2
|
Health Risk |
Pathogenic |
Corticosterone 18-monooxygenase deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS104894073 |
GATA4
|
Health Risk |
Pathogenic |
Atrial septal defect 2, Transposition of the great arteries |
| RS104894074 |
GATA4
|
Health Risk |
Pathogenic |
Atrial septal defect 2, Atrial septal defect 2 |
| RS104894075 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease axonal type 2K |
| RS104894076 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS104894077 |
GDAP1
|
Health Risk |
Pathogenic |
Neuropathy, axonal |
| RS104894078 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease type 4A |
| RS104894079 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease type 4A |
| RS104894080 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease recessive intermediate A, Charcot-Marie-Tooth disease axonal type 2K |
| RS104894082 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinal dystrophy |
| RS104894083 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS104894085 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |